Helping new therapies developed in the lab today reach patients in the clinic tomorrow
At Stanford, we are positioned to deliver the best possible care to children and adults using minimally invasive image-guided approaches to enable both Precision Sampling as well as Precision Delivery.
The interventional radiology team at LPCH has a progressive and pioneering culture where advanced technologies are combined with innovative approaches, for both routine patient care as well as new interventional clinical trials.
Preclinical Development
Specifically, at LPCH we have state-of-the-art interventional facilities unlike any other place in the world which helps us to bring innovation directly to children so they can receive the best possible treatment.
Clinical Translation
Research-driven Pioneering Care
CLINICAL TRANSLATION
Clinical Trials We are leading multiple efforts to bring the latest technologies and innovative approaches to the patient’s bedside. Dr Thakor is actively involved in multiple clinical trials as a PI as well as a Co-PI or collaborator; some of these efforts include patients being treated with new technologies like high intensity focused ultrasound (HIFU), innovative procedures like autologous and allogenic islet transplantation, and pushing the boundaries for local delivery of therapies into the arterial supply of organs, like the bowel for children with IBD (i.e. Cronh’s disease and ulcerative colitis) or GvHD. Our vision is to allow IRIS to innovate in the laboratory and then seamlessly facilitate the translation of precision therapies (i.e. MSCs and MSC-EVs) into validated and optimized precision delivery pathways thereby enabling the treatment of diseases like kidney injury, liver injury, bowel injury, diabetes and organ rejection.
COMING SOON
